Isabel Campos Varela

Institutions of which they are part

Main researcher
Liver Diseases

Vall Hebron Institut de Recerca

Isabel Campos Varela

Institutions of which they are part

Main researcher
Liver Diseases

Vall Hebron Institut de Recerca

Projects

Recerca clínica i traslacional en malalties hepàtiques

IP: -
Collaborators: Isabel Campos Varela
Funding agency: Instituto de Salud Carlos III
Funding: 108000
Reference: CM10/00294
Duration: 01/01/2011 - 31/12/2013

TOH/VIH-05: Trasplante hepático en pacientes infectados por el VIH en España (2005-2007) TOH/VIH-09: Trasplante hepático en pacientes infectados por el VIH en España (2009-2011)

IP: Lluis Castells Fusté
Collaborators: Isabel Campos Varela
Funding agency: Fundación Innov. y Prosp. Salud en España - FIPSE
Funding: 76100
Reference: FIPSE/TOH/VIH
Duration: 01/02/2006 - 31/01/2012

Related news

Vall d’Hebron participates in a consensus to optimize equity in access to liver transplant

The consensus establishes recommendations that could correct the current disparities related to muscle mass, weight and height and would allow for more precise prioritization of patients who require transplants more urgently.

We develop a method to diagnose fatty liver in a quantitative and non-invasive way

Using computed tomography (CT), with or without contrast, it is possible to perform an accurate and safe detection of the disease without the need for biopsies and avoiding the limitations of other non-invasive diagnostic tools.

Pacient d'un assaig clínic a la consulta

VHIR exceeds 700 active clinical trials to achieve new therapies for patients

On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.